Universitätsklinikum Schleswig-Holstein
Universitätsklinikum Schleswig-Holstein
Kiel, Schleswig-Holstein, Germany4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 3 | 2026-04-24 | NCT04666038 | |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-04-21 | NCT03188874 | |
| T-cell Therapy in Patients With PML | DNA Virus Infections, Encephalitis, Viral, Infections, Leukoencephalopathies, Neuroinflammatory Diseases, Slow Virus Diseases, brain disorder, central nervous system disorder, central nervous system infectious disorder, demyelinating disease, encephalitis, infectious encephalitis, nervous system disorder, polyomavirus infectious disease, progressive multifocal leukoencephalopathy, viral infection of central nervous system, viral infectious disease | Recruiting | Phase 2 | 2026-02-12 | NCT06990087 | |
| Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2023-05-06 | NCT03948035 |